Fuelled by a $10M gift from the Temerty Foundation, a team of Western University researchers have discovered a protein that could lead to a treatment for amyotrophic lateral sclerosis (ALS).
ALS, also known as Lou Gehrig’s disease, is a debilitating neurodegenerative disease that progressively impairs muscle control, leading to paralysis and death. The new discovery shows that a protein can reverse, halt or prevent the death of motor neurons, which are responsible for movement. The potential treatment pathway will target protein interactions that can prevent nerve cell death.
With a goal to bring this potential treatment to human clinical trials in five years, this breakthrough research marks a significant advancement in ALS research, offering hope for patients with ALS in finding effective treatments in the near future.
For more information, visit Western University.
